FGF2 and non-small cell lung carcinoma: Furthermore, Ware et al. (30) have reported that gefitinib-resistant cells after chronic exposure of several NSCLC cell lines to gefitinib showed increased expression of both mRNA and protein for FGFR1 and FGF2.